Nectar Lifesciences Limited (NSE:NECLIFE)

Nectar Lifesciences Revenue

In the fiscal year ending March 31, 2026, Nectar Lifesciences had annual revenue of 92.91M INR, down -99.44%. Nectar Lifesciences had revenue of 75.80M in the quarter ending March 31, 2026, a decrease of -98.23%.

• Revenue: 92.91M
• Revenue Growth: -99.44%
• P/S Ratio: 25.28
• Revenue / Employee: 52.02K
• Employees: 1,786
• Market Cap: 2.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	92.91M	-16.61B	-99.44%
Mar 31, 2025	16.70B	-142.05M	-0.84%
Mar 31, 2024	16.85B	1.61B	10.56%
Mar 31, 2023	15.24B	-1.45B	-8.70%
Mar 31, 2022	16.69B	1.26B	8.13%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error